Zantac/Ranitidine Registry Consent by Counsel

If you have any issues completing this form, please contact LMI technical support by calling 440-484-2030.

Pursuant to PTO # 37, all Plaintiffs' or Claimants' Counsel in MDL No. 2924 must complete this acknowledgment of the terms of use for the Registry. 
ONLY ONE REGISTRY CONSENT SHALL BE COMPLETED FOR EACH LAW FIRM

I have reviewed PTO # 37 and understand that if my law firm elects (now or in the future) to enroll any Claimant in the voluntary Registry created in MDL No. 2924, then the following terms will apply to our firm’s Zantac/ranitidine clients:

 

a. Each Claimant is bound by the terms of the existing PTOs, consents to the authority of the Court to issue additional PTOs governing Claimants, including but not limited to those furthering the Registry’s purpose of assisting parties in the joint investigation and assessment of potential claims, and consents to this Court’s jurisdiction as to the operation of the Registry, common benefit funds, and any other dispute related to the operation of any PTO in this MDL or contract related to the Registry.

 

b. In order to negotiate these PTOs, each Claimant agrees that Lead Counsel is authorized to represent them in these negotiations and, more broadly, to act on their behalf to the same extent as a Filed Plaintiff in this MDL.  The scope of this authorization is that set forth in PTO # 20.

 

c. All Claimants have a full right of access to the work product of this MDL, such work product shall be kept confidential, and counsel contractually agree that as a result, ALL of the firm’s Zantac/ranitidine clients will benefit from the MDL work product and thus are subject to the common benefit holdback issued by this Court with respect to common benefit fees and expenses (if any). 
 

On behalf of my firm and all present/future clients we represent with respect to the subject matter of this MDL, I expressly affirm my understanding of the Registry's structure and the obligations of opting into the voluntary Registry as set forth above.
 

Per PTO # 37, this consent form must be completed by an attorney.